Amphiphilic Polyoxazoline‐block‐Polypeptoid Copolymers by Sequential One‐Pot Ring‐Opening Polymerizations

Xianfu Pan,Yaya Liu,Zhenjiang Li,Saide Cui,Hailemariam Gebru,Jiaxi Xu,Songquan Xu,Jiaqi Liu,Kai Guo
DOI: https://doi.org/10.1002/macp.201600483
IF: 2.996
2017-01-01
Macromolecular Chemistry and Physics
Abstract:Amphiphilic block copolymers possess great potential as biomaterials in drug delivery and gene therapy. Herein, pseudopeptidic-type diblock copolymer of poly(2-oxazoline)-block-polypeptoid (POx-b-POI) is presented and synthesized. Poly[2-(3-butenyl)-2-oxazoline]-block-poly(sarcosine) (PBuOx-b-PSar) comprising hydrophobic POx segment bearing alkenyl side chain and hydrophilic POI segment of N-methyl glycine, viz., sarcosine, is prepared by ring-opening polymerization (ROP) through a one-pot and three-step route. Diphenyl phosphate initiates ROP of BuOx, and then the living chain end of PBuOx is quenched by ammonia to obtain PBuOx-ammonium phosphate in situ, the active ammonium group initiates ROP of sarcosine N-carboxy anhydride. PBuOx-b-PSar with controlled molecular weights (4.7-10.8 kg mol-1) and narrow dispersities (D-M 1.15-1.21) are characterized by H-1 NMR, C-13 NMR, and size-exclusion chromatography. Dynamic light scattering and transmission electron microscopy analysis reveal that PBuOx-b-PSar self-assembles into nanostructures of average diameter DH of 37-109 nm in aqueous solution. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test demonstrates the cytocompatibility (relative cell viability > 80%) of the PBuOx-b-PSar. In view of the selfassembly and biocompatibility, the readily prepared diblock copolymers may hopefully be used in biomedical applications.
What problem does this paper attempt to address?